These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11120572)

  • 21. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
    Engerman RL; Kern TS
    Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats.
    Kowluru RA
    Diabetes; 2003 Mar; 52(3):818-23. PubMed ID: 12606525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
    Gardiner TA; Anderson HR; Stitt AW
    J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.
    Kowluru RA; Koppolu P; Chakrabarti S; Chen S
    Free Radic Res; 2003 Nov; 37(11):1169-80. PubMed ID: 14703729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
    Roufail E; Soulis T; Boel E; Cooper ME; Rees S
    Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of pericyte loss by trolox in diabetic rat retina.
    Ansari NH; Zhang W; Fulep E; Mansour A
    J Toxicol Environ Health A; 1998 Jul; 54(6):467-75. PubMed ID: 9661912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
    Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
    Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress in rats after 60 days of hypergalactosemia or hyperglycemia.
    Otsyula M; King MS; Ketcham TG; Sanders RA; Watkins JB
    Int J Toxicol; 2003; 22(6):423-7. PubMed ID: 14680989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery.
    Osicka TM; Yu Y; Lee V; Panagiotopoulos S; Kemp BE; Jerums G
    Clin Sci (Lond); 2001 Mar; 100(3):249-57. PubMed ID: 11222110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes.
    Djordjevic B; Cvetkovic T; Stoimenov TJ; Despotovic M; Zivanovic S; Basic J; Veljkovic A; Velickov A; Kocic G; Pavlovic D; Sokolovic D
    Eur J Pharmacol; 2018 Aug; 833():290-297. PubMed ID: 29890158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
    Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.
    Kern TS; Engerman RL
    Curr Eye Res; 1994 Dec; 13(12):863-7. PubMed ID: 7720392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats.
    Luo D; Fan Y; Xu X
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4386-90. PubMed ID: 22627042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subnormal retinal oxygenation response precedes diabetic-like retinopathy.
    Berkowitz BA; Kowluru RA; Frank RN; Kern TS; Hohman TC; Prakash M
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2100-5. PubMed ID: 10440266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats.
    Moustafa SA
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):149-55. PubMed ID: 15541754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
    Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
    Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.
    Kowluru RA; Odenbach S
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4161-6. PubMed ID: 15505070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.
    Kern TS; Engerman RL
    Diabetes; 2001 Jul; 50(7):1636-42. PubMed ID: 11423486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.